CA-GILEAD-SCIENCES
9.5.2018 22:32:03 CEST | Business Wire | Press release
Gilead Sciences, Inc. (Nasdaq: GILD) announced today that Harish M. Manwani has been appointed to the company’s Board of Directors.
Mr. Manwani is a Global Executive Advisor to the private equity business of Blackstone, a leading asset management company. He was previously Chief Operating Officer of the global consumer products company Unilever PLC. He began his career at Unilever in 1976 and held senior management positions in Unilever businesses around the world for nearly 40 years. He brings broad international operational expertise, having worked extensively in Asia, Africa, Europe and the Americas. Mr. Manwani is currently the Chairman of Hindustan Unilever Ltd., and serves on the Boards of Nielsen Holdings PLC, Qualcomm Inc. and Whirlpool Corp. He is also on the Board of Economic Development Board of Singapore and is the Chairman of the Board of Indian School of Business.
“We are very pleased to welcome Harish Manwani to our Board of Directors,” said John Milligan, Ph.D., President and Chief Executive Officer, Gilead Sciences. “Harish brings extensive experience in driving growth across complex organizations on a global scale. His expertise will help guide our strategy as Gilead continues to grow in new geographies and address unmet medical needs for people around the world.”
About Gilead Sciences
Gilead Sciences is a biopharmaceutical company that discovers, develops and commercializes innovative therapeutics in areas of unmet medical need. The company’s mission is to advance the care of patients suffering from life-threatening diseases worldwide. Gilead has operations in more than 35 countries worldwide, with headquarters in Foster City, California.
For more information on Gilead Sciences, please visit the company’s website at www.gilead.com , follow Gilead on Twitter (@GileadSciences) or call Gilead Public Affairs at 1-800-GILEAD-5 or 1-650-574-3000.
View source version on businesswire.com: https://www.businesswire.com/news/home/20180509006474/en/
Contact:
Gilead Sciences, Inc.
Investors
Sung Lee, 650-524-7792
or
Media
Mark
Snyder, 650-522-6167
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Carta Rearchitects Private Capital Operations with Plugins for Claude29.7.2026 16:01:00 CEST | Press release
Firms managing billions in assets are cutting days of manual fund and portfolio work down to a single prompt — a shift now available to all Carta customers through Anthropic's official plugin directory. Carta, the connected platform and AI-native ecosystem for private capital, today announces broad availability of its suite of Plugins for Claude following the initial launch in April 2026. With more than 1,500 companies and firms already using the plugins, Carta is changing the way private capital teams — from founders to CFOs — fundamentally operate, bringing fund administration, cap table management, and dealflow analytics directly into the spreadsheets, presentations, and workflows they already use every day. "For the last decade, private capital operation teams have been held back by a hidden tax: the constant, manual handoff of data between disconnected systems," said Henry Ward, Carta CEO. "Carta is eliminating that broken loop entirely by embedding intelligence directly into the
Experian Recognized by Chartis Research for Advancing AI Model Governance in Quantitative Analytics50 202629.7.2026 15:00:00 CEST | Press release
Global data and technology company recognized for helping financial institutions accelerate AI innovation with trusted model governance, transparency and regulatory control Key Highlights Chartis Research recognized Experian as the category winner for Model Risk Management Environment in the Quantitative Analytics50 2026 report. Experian Ascend Platform™ enables organizations to move from model development to governed production with transparency, traceability and policy-driven controls. Recognition validates Experian's approach to helping lenders and financial institutions accelerate AI adoption while strengthening compliance, explainability and model risk governance. Experian today announced it has been recognized by Chartis Research as the winner in the Model Risk Management Environment category in the Quantitative Analytics50 2026 report. The recognition marks Experian's first appearance in the prestigious ranking and reinforces the company's position as a leading provider of data
Grid Dynamics Accelerates Enterprise AI-Native Transformation With Workforce Certification and GAIN Platforms Rollout29.7.2026 15:00:00 CEST | Press release
Key Takeaways: Grid Dynamics plans to have 90% of its engineers trained and certified on Anthropic and OpenAI platforms by the end of October 2026. At one of North America's largest home improvement retailers, Grid Dynamics has scaled its GAIN (Grid Dynamics AI Native) Platform for AI SDLC by expanding its agentic harness technology to more than 500 additional engineers. Grid Dynamics Holdings, Inc. (Nasdaq: GDYN) (“Grid Dynamics”), a leading provider of technology consulting, platform and product engineering, and AI-driven digital transformation services, today announced significant momentum in the adoption of its enterprise agentic AI solutions. Organizations across retail, financial services, manufacturing, CPG, and logistics industries are increasingly deploying Grid Dynamics’ agentic AI-native platforms and Forward Deployed Engineering (FDE)-led services to accelerate software delivery, improve operational efficiency, and transform business processes at scale. Grid Dynamics is wid
VDyne Announces First Patient Treated in TRIVITA US IDE Pivotal Study of the TriNova™ Transcatheter Tricuspid Valve Replacement System29.7.2026 15:00:00 CEST | Press release
VDyne Inc. (“VDyne”), a privately held medical device company developing an innovative transcatheter tricuspid valve replacement (TTVR) system, today announced that the first patient has been enrolled and treated in the TRIVITA US IDE pivotal study of the TriNova™ system. The randomized controlled study will compare TriNova head-to-head with the commercially available Edwards EVOQUE™ TTVR system. The TRIVITA trial (NCT07516444) initiation marks a significant milestone in advancing treatment for tricuspid regurgitation (TR). The prospective, global, multicenter, randomized (1:1) controlled study is designed to evaluate the safety and effectiveness of the TriNova TTVR system in patients with severe or greater tricuspid regurgitation who are suitable for valve replacement. The study will be conducted in the US and Europe with up to 70 sites participating. The first patient was enrolled at the Allina Health Minneapolis Heart Institute at Abbott Northwestern Hospital in Minneapolis, and tre
New Continuous Delivery Loop Framework From Coherent Solutions Closes the AI Value Gap for Software Engineering Teams Moving From AI-Assisted to AI-Native Development29.7.2026 15:00:00 CEST | Press release
The company's early results show an approximately 30% delivery-performance gain when AI tool adoption is paired with operating model change Software teams are generating code faster than ever with AI, yet many see the bottleneck shifting to delivery speed and code quality. Coherent Solutions, a global digital engineering firm, argues in its recent whitepaper that the problem lies in traditional SDLC processes that aren't built for AI's speed. It introduces an operating framework designed to close that gap, called the Continuous Delivery Loop (CDL). This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260729426213/en/ New Continuous Delivery Loop framework from Coherent Solutions The whitepaper, “From traditional SDLC to the Continuous Delivery Loop,” is available to download for free. The whitepaper also describes what the company calls the "Digital Value Gap," which exists between accelerated developer activity and actual busines
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom